Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab in untreated locally advanced SCCHN
NCT01305772Phase 2Terminated
- Start
- Jan 2011
- Primary completion
- Mar 2012
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label trial of panitumumab in squamous cell carcinoma of the head and neck (HNSCC). Started Jan 2011; status: terminated.
02
Drugs
panitumumab
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01305772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01305772.